MALAIKA EYECARE LTDActive

Company number 10690205Private limited companyIncorporated 2017
⚠ Accounts overdue. The next accounts were due on 2 Oct 2026 and had not been filed when the register was last updated.

Key figures

£22,817+0.0%
Net assets 2024/25
+8.6%
Average annual growth 2019/20–2024/25
010 k20 k30 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, MALAIKA EYECARE LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets203,100203,100203,100203,100203,100
Total liabilities225,917225,917225,917225,917225,917
Net assets / total equity22,81722,81722,81722,81722,817
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: MALAIKA EYECARE LTD

Company

MALAIKA EYECARE LTD is a private limited company registered with Companies House under company number 10690205. It was incorporated on 24 Mar 2017. Its status is active. The registered office is in London (E1). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 2 Jan 2025); the company files micro-entity accounts. Net assets were £22,817, up 0% on the previous year. Total assets were £203,100 and total liabilities £225,917. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 2 Oct 2026. The next confirmation statement is due by 6 Apr 2027.